Improving the evaluation of therapeutic interventions in multiple sclerosis: the role of new psychometric methods

被引:451
|
作者
Hobart, J. [1 ]
Cano, S. [2 ]
机构
[1] Peninsula Coll Med & Dent, Dept Clin Neurosci, Neurol Outcome Measures Unit, Plymouth, Devon, England
[2] Inst Neurol, London WC1N 3BG, England
关键词
IMPACT SCALE MSIS-29; QUALITY-OF-LIFE; FUNCTIONAL INDEPENDENCE MEASURE; HEALTH-STATUS INSTRUMENTS; ITEM RESPONSE THEORY; BARTHEL INDEX; WALKING SCALE; INPATIENT REHABILITATION; COEFFICIENT ALPHA; DISABILITY SCALE;
D O I
10.3310/hta13120
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objectives: In this monograph we examine the added value of new psychometric methods (Rasch measurement and Item Response Theory) over traditional psychometric approaches by comparing and contrasting their psychometric evaluations of existing sets of rating scale data. We have concentrated on Rasch measurement rather than Item Response Theory because we believe that it is the more advantageous method for health measurement from a conceptual, theoretical and practical perspective. Our intention is to provide an authoritative document that describes the principles of Rasch measurement and the practice of Rasch analysis in a clear, detailed, non-technical form that is accurate and accessible to clinicians and researchers in health measurement. Review methods: A comparison was undertaken of traditional and new psychometric methods in five large sets of rating scale data: (1) evaluation of the Rivermead Mobility Index (RMI) in data from 666 participants in the Cannabis in Multiple Sclerosis (CAMS) study; (2) evaluation of the Multiple Sclerosis Impact Scale (MSIS-29) in data from 1725 people with multiple sclerosis; (3) evaluation of test-retest reliability of MSIS-29 in data from 150 people with multiple sclerosis; (4) examination of the use of Rasch analysis to equate scales purporting to measure the same health construct in 585 people with multiple sclerosis; and (5) comparison of relative responsiveness of the Barthel Index and Functional Independence Measure in data from 1400 people undergoing neurorehabilitation. Results: Both Rasch measurement and Item Response Theory are conceptually and theoretically superior to traditional psychometric methods. Findings from each of the five studies show that Rasch analysis is empirically superior to traditional psychometric methods for evaluating rating scales, developing rating scales, analysing rating scale data, understanding and measuring stability and change, and understanding the health constructs we seek to quantify. Conclusions: There is considerable added value in using Rasch analysis rather than traditional psychometric methods in health measurement. Future research directions include the need to reproduce our findings in a range of clinical populations, detailed head-to-head comparisons of Rasch analysis and Item Response Theory, and the application of Rasch analysis to clinical practice. © 2009 Queen's Printer and Controller of HMSO. All rights reserved.
引用
收藏
页码:1 / +
页数:174
相关论文
共 50 条
  • [21] NEW THERAPEUTIC OPTIONS IN THE TREATMENT OF MULTIPLE SCLEROSIS
    Barun, B.
    Brinar, V.
    NEUROLOGIA CROATICA, 2008, 57 (1-2): : 23 - 34
  • [22] Statins in multiple sclerosis: a new therapeutic option?
    Neuhaus, O
    Archelos, JJ
    Hartung, HP
    MULTIPLE SCLEROSIS JOURNAL, 2003, 9 (05) : 429 - 430
  • [23] Multiple sclerosis: new insights and therapeutic progress
    Miller, David
    LANCET NEUROLOGY, 2007, 6 (01): : 5 - 6
  • [24] NEW THERAPEUTIC STRATEGIES IN MULTIPLE-SCLEROSIS
    LAUER, K
    FIRNHABER, W
    NERVENARZT, 1988, 59 (09): : 495 - 503
  • [25] A New Therapeutic Target for the Treatment of Multiple Sclerosis
    Poulter, Michael O.
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2012, 39 (05) : 570 - 570
  • [26] Neddylation — a new therapeutic target for multiple sclerosis?
    Wood H.
    Nature Reviews Neurology, 2021, 17 (2) : 64 - 64
  • [27] Natalizumab as new therapeutic option for multiple sclerosis
    Linker, R. A.
    Hohlfeld, R.
    Gold, R.
    AKTUELLE NEUROLOGIE, 2008, 35 (02) : 89 - 96
  • [28] New therapeutic strategies for remyelination in multiple sclerosis
    Kremer, D.
    Hartung, H-P.
    Stangel, M.
    Kuery, P.
    NERVENARZT, 2015, 86 (08): : 934 - +
  • [29] Ocrelizumab: A New Therapeutic Paradigm for Multiple Sclerosis
    Chin, Peter
    Chan, Andrew C.
    BIOCHEMISTRY, 2018, 57 (05) : 474 - 476
  • [30] Distinct mechanisms of oligodendrocyte injury inform therapeutic interventions in multiple sclerosis
    Garton, Thomas
    Gill, Alexander J.
    Calabresi, Peter A.
    BRAIN, 2022, 145 (12) : 4151 - 4153